Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 13/20 | 0.63 |
| ▸ | NPY1R | P25929 | 8/20 | 0.63 |
| ▸ | NPY2R | P49146 | 6/20 | 0.63 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.63 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.56 |
| ▸ | LTA4H | P09960 | 1/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30900192 | 0.97 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5RKISS1R | |
| SCHEMBL30900089 | 0.96 | NPY4R (0.66) | NPY4RNPY1RNPY2RNPY5RKISS1R | |
| SCHEMBL31222396 | 0.94 | NPY4R (0.66) | NPY4RNPY1RNPY2RNPY5RKISS1R | |
| SCHEMBL23405252 | 0.93 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5RKISS1R | |
| SCHEMBL23405249 | 0.93 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5RKISS1R | |
| SCHEMBL30833334 | 0.93 | NPY4R (0.59) | NPY4RNPY1RNPY2RNPY5RKISS1R | |
| SCHEMBL31361466 | 0.93 | NPY4R (0.59) | NPY4RNPY1RNPY2RNPY5RKISS1R | |
| SCHEMBL29586394 | 0.92 | NPY4R (0.66) | NPY4RNPY1RNPY2RNPY5RKISS1R | |
| SCHEMBL29580364 | 0.91 | NPY4R (0.60) | NPY4RNPY1RNPY2RNPY5RKISS1R | |
| SCHEMBL9763738 | 0.90 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5RKISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118724903-A | Compound with fused ring structure, its preparation method and use, and pharmaceutical composition and use | 苏州安赛隆医药科技有限公司 | 2024-10-01 | — | — | CN | disclosed |
| US-20220143024-A1 | METHODS OF USING IMIPRIDONES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-05-12 | — | — | US | disclosed |